VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 105 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 12.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,921,000 | -30.8% | 4,455,836 | -2.5% | 0.37% | -7.9% |
| Q1 2022 | $5,667,000 | -32.2% | 4,570,387 | +6.6% | 0.40% | -23.8% |
| Q4 2021 | $8,362,000 | +9.5% | 4,288,077 | +53.9% | 0.53% | -5.0% |
| Q3 2021 | $7,635,000 | -12.0% | 2,786,354 | +1.2% | 0.56% | +2.4% |
| Q2 2021 | $8,675,000 | +88.5% | 2,753,880 | +27.4% | 0.54% | +69.5% |
| Q1 2021 | $4,603,000 | – | 2,161,002 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|